• OPEN AN ACCOUNT
Indian Indices
Nifty
24,620.20 77.70
(0.32%)
Sensex
80,998.25 260.74
( 0.32%)
Bank Nifty
55,676.85 76.90
( 0.14%)
Nifty IT
36,938.10 123.20
( 0.33%)
Global Indices
Nasdaq
42,543.92 217.44
(0.51%)
Dow Jones
5,991.81 34.87
(0.59%)
Hang Seng
37,806.65 359.84
(0.96%)
Nikkei 225
8,787.02 12.76
(0.15%)
Forex
USD-INR
85.40 -0.14
(-0.17%)
EUR-INR
97.46 0.39
(0.40%)
GBP-INR
115.51 0.44
(0.39%)
JPY-INR
0.60 0.00
(0.58%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
561.0868795
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
78.48
173357.62
EPS(TTM)
Face Value()
Div & Yield %
83.21
2
0.46
 

divis laboratories ltd
Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.
May 24,2025
Divis Laboratories has entered into a long term manufacturing and supply agreement with a global pharma company.

Under this agreement, the Company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties.

The Company expects meaningful revenue contribution from this long-term agreement.

Cost of capacity addition for manufacturing under this agreement is estimated to be Rs.650-750 crore, which will be funded from the capacity reservation advance proposed to be paid by the customer phase wise under this Agreement.